These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32645315)

  • 21. Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use.
    Fischer B; Kuganesan S; Gallassi A; Malcher-Lopes R; van den Brink W; Wood E
    Int J Drug Policy; 2015 Dec; 26(12):1177-82. PubMed ID: 26500166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for cannabidiol in psychiatry?
    Khoury JM; Neves MCLD; Roque MAV; Queiroz DAB; Corrêa de Freitas AA; de Fátima Â; Moreira FA; Garcia FD
    World J Biol Psychiatry; 2019 Feb; 20(2):101-116. PubMed ID: 28112021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice.
    Assareh N; Gururajan A; Zhou C; Luo JL; Kevin RC; Arnold JC
    Behav Pharmacol; 2020 Sep; 31(6):591-596. PubMed ID: 32483052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol effects on cognition in individuals with cocaine use disorder: Exploratory results from a randomized controlled trial.
    Rizkallah E; Mongeau-Pérusse V; Lamanuzzi L; Castenada-Ouellet S; Stip E; Juteau LC; Brissette S; Bruneau J; Dubreucq S; Jutras-Aswad D
    Pharmacol Biochem Behav; 2022 May; 216():173376. PubMed ID: 35367279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.
    Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T
    Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A scoping review of the use of cannabidiol in psychiatric disorders.
    Kirkland AE; Fadus MC; Gruber SA; Gray KM; Wilens TE; Squeglia LM
    Psychiatry Res; 2022 Feb; 308():114347. PubMed ID: 34952255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance.
    Narayan AJ; Downey LA; Manning B; Hayley AC
    Neurosci Biobehav Rev; 2022 Dec; 143():104941. PubMed ID: 36370842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results From a Randomized Controlled Trial.
    Mongeau-Pérusse V; Rizkallah E; Morissette F; Brissette S; Bruneau J; Dubreucq S; Gazil G; Trépanier A; Jutras-Aswad D
    J Addict Med; 2022 Sep-Oct 01; 16(5):521-526. PubMed ID: 35135986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
    Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal.
    Gasparyan A; Navarrete F; Rodríguez-Arias M; Miñarro J; Manzanares J
    Neurotherapeutics; 2021 Jan; 18(1):615-623. PubMed ID: 33230690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological effects of Cannabidiol on normal human healthy cell populations: Systematic review of the literature.
    Pagano S; Coniglio M; Valenti C; Federici MI; Lombardo G; Cianetti S; Marinucci L
    Biomed Pharmacother; 2020 Dec; 132():110728. PubMed ID: 33038581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
    Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.
    Breuer A; Haj CG; Fogaça MV; Gomes FV; Silva NR; Pedrazzi JF; Del Bel EA; Hallak JC; Crippa JA; Zuardi AW; Mechoulam R; Guimarães FS
    PLoS One; 2016; 11(7):e0158779. PubMed ID: 27416026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol as a Potential Treatment for Anxiety Disorders.
    Blessing EM; Steenkamp MM; Manzanares J; Marmar CR
    Neurotherapeutics; 2015 Oct; 12(4):825-36. PubMed ID: 26341731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia.
    Thériault RK; St-Denis M; Hewitt T; Khokhar JY; Lalonde J; Perreault ML
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review.
    Turna J; Syan SK; Frey BN; Rush B; Costello MJ; Weiss M; MacKillop J
    Alcohol Clin Exp Res; 2019 Apr; 43(4):550-563. PubMed ID: 30698831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
    Bonaccorso S; Ricciardi A; Zangani C; Chiappini S; Schifano F
    Neurotoxicology; 2019 Sep; 74():282-298. PubMed ID: 31412258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.